Alpha DNA Investment Management »

Tarsus Pharmaceuticals shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $506k 14k 36.35

More positions owned by Alpha DNA Investment Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Chubb (CB)
McDonald's Corporation (MCD)
Mondelez Intl Cl A (MDLZ)
Merck & Co (MRK)
Wal-Mart Stores (WMT)
Union Pacific Corporation (UNP)
Wells Fargo & Company (WFC)
Apple (AAPL)
Cigna Corp (CI)
Bank of America Corporation (BAC)
Nextera Energy (NEE)

View all positions for Alpha DNA Investment Management

Top funds holding Tarsus Pharmaceuticals

Paradigm Biocapital Advisors
BlackRock
Morgan Stanley
Tang Capital Management
Cormorant Asset Management
Cowen And Company
Vanguard Group
Frazier Life Sciences Management
Jennison Associates
Perceptive Advisors
Ikarian Capital
Ensign Peak Advisors
Geode Capital Management
Artisan Partners Limited Partnership
Boone Capital Management

View all funds holding Tarsus Pharmaceuticals